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Apoptosis is an evolutionarily conserved form of physiologic cell death important for tissue
development and homeostasis. The causes and execution mechanisms of apoptosis are not
completely understood. Nitric oxide (NO) and its congeners, oxidative stress, Ca>+, proteases,
nucleases, and mitochondria are considered mediators of apoptosis. Recent findings strongly
suggest that mitochondria contain a factor or factors that upon release from the destabilized
organelles, induce apoptosis. We have found that oxidative stress-induced release of Ca2+ from
mitochondria followed by Ca2+ reuptake (Ca2+ cycling) causes destabilization of mitochondria and
apoptosis. The protein product of the protooncogene bcl-2 protects mitochondria and thereby
prevents apoptosis. We have also found that NO and its congeners can induce Ca2+ release from
mitochondria. Thus, nitrogen monoxide ('NO) binds to cytochrome oxidase, blocks respiration,
and thereby causes mitochondrial deenergization and Ca2+ release. Peroxynitrite (ONOO-), on the
other hand, causes Ca2+ release from mitochondria by stimulating a specific Ca2+ release
pathway. This pathway requires oxidized nicotinamide adenine dinucleotide (NAD+) hydrolysis to
adenosine diphosphate ribose and nicotinamide. NAD+ hydrolysis is only possible when some
vicinal thiols are cross-linked. ONOO- is able to oxidize them. Our findings suggest that NO and
its congeners can induce apoptosis by destabilizing mitochondria via deenergization and/or by
inducing a specific Ca2+ release followed by Ca2+ cycling. Environ Health Perspect 106(Suppl 5):
1125-1130 (1998). http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-5/1 125-1 13Orichter/abstract.html
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Mitochondria and Cell Death
Ca2'IinducMNecrotic andApoptotic
Cell Death
Apoptosis is an evolutionarily conserved
form of physiologic cell death important
for tissue development and homeostasis. Its
hallmarks are distinct morphologic alter-
ations such as nuclear condensation, cell
shrinkage, and bleb formation, and the
absence of inflammatory responses of the
affected tissue. Deranged apoptosis plays a
major role in diseases such as cancer,
aquired immune deficiency syndrome,
autoimmune diseases, and neurodegenera-
tion [reviewed byThompson (1)].
Necrosis and apoptosis are distinct
forms of cell death, the former being a
passive process typified by gross damage
and spillage ofthe intracellular content, the
latter being a highly regulated and con-
trolled process that avoids inflammation
and damage to the surrounding tissue (2).
Attention was drawn to Ca2+-induced cell
death many years ago [(3); for a recent
review see Trump and Berezesky (4)].
Excessive intracellular Ca2+ is thought to
contribute to a final common pathway of
This paper is based on a presentation at the Second International Meeting on Oxygen/Nitrogen Radicals
and Cellular Injury held 7-10 September 1997 in Durham, North Carolina. Manuscript received at EHP 19
December 1997; accepted 3 April 1998.
The work performed in the author's laboratory was generously supported over the years by the
Schweizerische Nationalfonds, and partly by the Eidgenbssische Technische Hochschule Zurich. Drs.
Gogvadze, Schlegel, Schweizer, and Suter were also supported by The European Science Foundation, by
the Schweizerische Krebsliga, and by an anonymous sponsor.
Address correspondence to C. Richter, Laboratory of Biochemistry I, Swiss Federal Institute of
Technology (ETH), Universitatstr. 16, CH-8092 Z5rich, Switzerland. Telephone: 41 1 632 31 36 or 30 21.
Fax: 41 1 632 11 21. E-mail: richter@bc.biol.ethz.ch
Abbreviations used: CSA, cyclosporine A; DY, mitochondrial membrane potential; GSNO/DTT, nitrosog-
lutathione in combination with dithiothreitol; NAD+, oxidized nicotinamide adenine dinucleotide; NO, nitric
oxide independent of redox state-nitrogen monoxide radical, nitrosonium ion, nitroxyl anion; 'NO, nitro-
gen monoxide; NO+, nitrosonium ion; NO-, nitroxyl anion; NOS, nitric oxide synthase; 02-, superoxide
anion radical; ONOO-, peroxynitrite; ROS, reactive oxygen species.
cytotoxic events leading to formation of
reactive oxygen species (ROS) and necrosis
or apoptosis. These events include over-
activation of protein kinase C, Ca2+/
calmodulin-dependent protein kinase II,
phospholipases, proteases, protein phos-
phatases, xanthine oxidase, endonucleases,
and nitric oxide synthase (NOS).
Although the exact role of Ca2+ in cell
killing is unclear, a disturbance of mito-
chondrial Ca2+ handling can be fatal [for
reviews see Nicotera et al. (5) and Richter
(6)]. The normal Ca2+ uptake and release
(cycling) across the inner mitochondrial
membrane requires little energy (7).
However, when the Ca2+ release pathway is
stimulated by prooxidants, cycling may
become excessive and lead to loss of the
mitochondrial membrane potential (DY),
general leakiness ofthe inner mitochondrial
membrane, inhibition ofadenosine triphos-
phate (ATP) synthesis, mitochondrial
damage, and cell death (8).
Several conditions, molecules, or
organelles such as oxidative stress, Ca2+,
proteases, nucleases, or mitochondria are
considered participants ofapoptosis, but at
present it is not always clear whether they
are required for or are the consequence
ofapoptosis.
There is ample evidence that apoptosis
is accompanied by oxidative stress
[reviewed by Buttke and Sandstrom (9)].
A valuable tool used to elucidate the
importance of oxidative stress is the pro-
tooncogene bcl-2, which stimulates an
antioxidative response in cells and prevents
apoptosis (10,11).
The requirement ofCa2+ for apoptosis
is also controversial (12). Early reports
suggested that a rise of the intracellular
Ca2+ leads to apoptosis via endonuclease
activation, and more recent work indicated
that apoptosis is accompanied by shifts of
Ca2+ between various intracellular pools. It
is worth noting that cellular Ca2+ handling
and ROS production are related. Thus,
increased mitochondrial Ca2+ release fol-
lowed by reuptake driven by DY (Ca2+
cycling) stimulates ROS production (13).
Mitochondria inApoptosis
Although the causes and execution
mechanisms of apoptosis are not clearly
understood, oxidative stress, NO (NO indi-
cates nitric oxide independent of its redox
state, whereas NO, NO+, and NO refer to
the nitrogen monoxide radical, nitrosonium
ion, and nitroxyl anion, respectively) and its
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congeners, Ca2 , proteases, nucleases, and
mitochondria are important mediators of
apoptosis. Recendy, the role ofmitochon-
dria, particularly in apoptosis, was scruti-
nized (14,15). At present, their importance
and exact role are elusive, but it is dear that
mitochondria are both the target and the
source ofoxidative stress, NO, and Ca2 .
During apoptosis DY, which is the driving
force for mitochondrial ATP synthesis,
declines, and maintenance ofDY prevents
apoptosis. Because apoptosis is highly regu-
lated and involves the activity ofhydrolytic
enzymes, chromatin condensation and vesi-
cle formation apoptosis is likely to have a
high energy demand. Indeed, it was
recently proposed that apoptosis induced
by intracellular Ca2+ overload in neurons
requires active mitochondria (16). We have
proposed (15) that the cellular ATP level is
an important determinant for cell death.
Another line of evidence also puts
mitochondria on the center stage ofapop-
tosis; when they are destabilized, for exam-
ple, by Ca2+ cycling, they release proteins,
some ofwhich induce apoptosis. One is
cytochrome c, which acts with cytosolic
factors to induce nuclear apoptosis (17).
The other is a 50-kDa protease that by
itself suffices to cause nuclear apoptosis
(18). The present knowledge suggests that
mitochondria function as a cellular sensors
ofstress into which very different apopto-
sis induction pathways converge and that
mitochondria act as central apoptotic
executioner (19).
Presently, apopularconcept in apoptosis
is the so-called mitochondrial permeability
transition, a phenomenon related to the
opening of a putative pore in the inner
mitochondrial membrane. In the author's
opinion, the mitochondrial permeability
transition represents the initial phase of
unspecific damage to mitochondria that
can, for example, be induced by mitochon-
drial Ca2+ cycling (20). Whether a pore
opens or mitochondria are unspecifically
damaged may not be relevant for apoptosis.
The crucial event appears to be the release
ofproapoptotic factors such as cytochrome
cor proteases from mitochondria.
NO in Mitochondria
BiologyofNO
NO presently receives enormous attention.
It mediates beneficial responses such as
maintenance ofblood pressure, inhibition
ofplatelet aggregation, tumoricidal activi-
ties, or destruction offoreign invaders in
the immune response, and is probably of
major importance in long-term memory.
However, when produced in excessive
amounts, NO can become toxic, for
example, during septic shock.
The dichotomy ofNO is in part due to
a broad array ofredox species with distinc-
tive properties and reactivities: NO+,
'NO, and NO- [reviewed by Stamler et al.
(21) and Stamler (22)], and the ability of
'NO to combine with superoxide anion
radicals (02--) to yield peroxynitrite
(ONOO-) (23).
ONOO- is an efficient oxidant ofthiols
(24). Its in vivo formation was recently
shown in a variety ofcells (25). ONOO-
production is associated with the activation
and expression ofinducible NOS and impli-
cated in the pathophysiologyofdiseases such
as acute endotoxemia, inflammatory bowel
disease, neurologic disorders, and atheroscle-
rosis. Inhibition by superoxide dismutase,
the 02-- scavenger, of'NO-mediated cyto-
toxicity suggests that ONOO- contributes
to theNO-mediated biologic effects (26).
NO- is formed from 'NO by reduced
superoxide dismutase (27). It is another
NO congener that oxidizes thiols. NO- is,
like ONOO-, neuroprotective at N-methyl-
D-aspartate receptors because these com-
pounds lead to disulfide formation at critical
thiols of the redox modulator site of the
receptor (28,29), which inhibits the Ca2+
entry into the cell.
NO inMitochondria
NitrogenMonoxideandtheRegwlation of
Cytochrome Oxidase. The most-cited and
best-understood physiologic target of 'NO
is guanyl cyclase. *NO binds to and stimu-
lates it and thus controls cell functions via
(cGMP), cGMP-gated channels, cGMP-
dependent protein kinases, and phosphodi-
esterases. However, 'NO also binds to
cytochrome oxidase and reversibly inhibits
respiration as seen with the isolated
enzyme, submitochondrial particles, mito-
chondria, hepatocytes, brain nerve termi-
nals, and astrocytes (30-36). Cytochrome
oxidase inhibition is competitive with oxy-
gen because ofbinding ofNO to the oxy-
gen binding site of the reduced enzyme
(37,38). Why the inhibition is transient is
not clear at the moment, but several find-
ings point to consumption of NO as the
underlying reason (39). Thus, cytochrome
oxidase can reduce NO (40), 'NO can
combine with 02 to form NON, and with
02 to form ONOO-.
Concentrations of 'NO measured in a
range of biologic systems are similar to
those that inhibit cytochrome oxidase and
mitochondrial respiration, and inhibition of
'NO synthesis results in a stimulation of
respiration in many systems. It was, there-
fore, proposed that 'NO exerts a good part
ofits physiologic and pathologic effects on
cells by inhibiting cytochrome oxidase (41).
Presence ofNitric Oxide Synthase in
Mitochondria. NOS is present within
mitochondria (42). This offers exciting new
insights into the biology ofNO. For exam-
ple, because the enzyme is stimulated by
Ca2+ and located in the matrix or at the
inner side ofthe inner mitochondrial mem-
brane, this may provide a self-regulating
system for mitochondrial Ca2+ homeostasis
in which Ca2+ uptake by mitochondria
would lead to 'NO formation. *NO could
promote Ca2+ release by collapsing DY via
inhibition ofcytochrome oxidase.
Other Putative Targets ofNO in
Mitochondria. 'NO not formed inside
mitochondria may also have a profound
impact on the organelles, as it is uncharged
and can easily traverse membranes. For
example, extramitochondrially formed
*NO could combine in mitochondria with
02'- and form ONOO-, which could then
stimulate Ca2+ release from mitochondria
with maintenance of DY. 'NO has been
compared with ONOO- as to its inhib-
itory capacity in mitochondria. Aconitase is
the principal site ofinhibition by ONOO-
(and 02-), whereas this enzyme is resistant
to 'NO (43,44).
Another possibility would be a *NO-
catalyzed auto-ADP-ribosylation of mito-
chondrial NAD+-binding proteins, as
reported for several cytosolic enzymes
(45,46). Also, mitochondria are rich in
glutathione and contain key sulfhydryl
enzymes such as the adenine nucleotide
translocator or creatine kinase that are
putative targets ofnitric oxide congeners.
Reactive Oxygen and
Nitrogen Species as
Regulators of Mitochondrial
Ca2+ Homeostasis
MitochondriaandCellular Qa2+Homeostasis
Intracellular Ca2+ regulates many processes.
Its concentration is adjusted by binding
to nonmembranous proteins, by mito-
chondria, and by membrane-bound
Ca2+-ATPases located primarily in the
plasma, nuclear, and endoplasmic reticular
membrane [reviewed by Carafoli (7)].
Mitochondria contain Ca2+-sensitive targets
regulated by moderate Ca2+ transients.
These organelles are also able to take up
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large amounts of Ca2+ and buffer the
cytosolic Ca2+. They thereby act as safety
devices against potentially toxic increases of
cytosolic Ca2+ [reviewed byRichterand Kass
(8)]. Mitochondria take up and release Ca2+
byseparate routes. As a consequence, Ca2+ is
cycledacross their innermembranes (7).
Mitochondria are ofcentral importance
for physiologic Ca2+ handling. They act as
a reservoir for Ca2+, provide much of the
ATP used by Ca2+-ATPases, and Ca2+
regulates the activity ofintramitochondrial
dehydrogenases as well as nucleic acid and
protein synthesis (47).
The importance of mitochondria as
short-term modulators ofcytosolic Ca2+
under physiologic conditions was until
recently considered minor. However,
there is now compelling evidence
[reviewed by Rizzuto et al. (48) and
Hajnoczky et al. (49)] that during physi-
ologic cell stimulation, mitochondrial
Ca2+ transport directly participates in the
modulation and maintenance of cellular
Ca2+ homeostasis. Several reports have
additionally documented that physiologic
cytosolic Ca2+ pulses are relayed into
mitochondria of brain, liver, and
Xenopous laevisoocytes (50-52).
Mitochondrial Ca2+ Release
In principle, Ca2+ can leave mitochondria
in three ways: by nonspecific leakage
through the inner membrane, by reversal of
the influx carrier, and by an Na+-dependent
or -independent release pathway (7,53).
Only the latter two are physiologically rel-
evant because they operate when DY is
high. The Na+-dependent pathway pre-
dominates in mitochondria of heart,
brain, skeletal muscle, adrenal cortex,
brown fat, and most tumor tissue. The
Na+-independent pathway is important in
liver, kidney, lung, and smooth muscle
mitochondria, probably exchanges Ca2+
with H+, and is linked to the redox state
of mitochondrial pyridine nucleotides.
Compounds causing their oxidation (and
hydrolysis) promote Ca2+ release from
intact mitochondria. This release has
recently been reviewed (8,47,54).
Prooidant-Induced, NAD+-Linlwd
C2+ Release
NAD+ Hydrolysis Is Requiredfor Ca2+
Release from Intact Mitochondria.
Hydrogen peroxide can stimulate a specific
Ca2+ release pathway from intact mito-
chondria by oxidizing mitochondrial
pyridine nucleotides through the activities
of glutathione peroxidase, glutathione
reductase, and the energy-linked trans-
hydrogenase. Other prooxidants such as
menadione, alloxan, and divicine also stim-
ulate the specific Ca2+ release because they
furnish NAD+. The specific Ca2+ release
requires for its activation the hydrolysis of
intramitochondrial NAD+ to ADP-ribose
and nicotinamide and is prevented by
inhibitors ofNAD+ hydrolysis and protein
mono(ADP-ribosyl)ation. Recent experi-
ments reveal that NAD+ hydrolysis and
therefore Ca2+ release is regulated by vici-
nal thiols in mitochondria. When reduced
or alkylated, the thiols prevent hydrolysis,
but when they are cross-linked, hydrolysis
takes place. Cyclosporine A (CSA), which
also prevents NAD+ hydrolysis, acts distal
ofthese vicinal thiols [for recent review see
Richter (55)].
NAD+ Hydrolysis Is under the
ControlofVicinal Thiols. NAD+ hydroly-
sis, and therefore ADP-ribosylation and
Ca2+ release, is under the control ofvicinal
thiols. Phenylarsine oxide, which reversibly
forms a five-membered ring with vicinal
thiols, promotes the Ca2+-dependent
intramitochondrial NAD+ hydrolysis and
thereby the specific Ca2+ release (56).
Gliotoxin, a fungal metabolite carrying a
disulfide moiety, also promotes the Ca2+-
dependent intramitochondrial NAD+
hydrolysis and thereby the specific Ca2+
release but is inactive when its sulfurs are
reduced or methylated (57). Thus, intra-
mitochondrial, Ca2+-dependent NAD+
hydrolysis is prevented when some vicinal
thiols are in the reduced SH-form, and
occurs when they are connected, either by
a cross-linking reagent or by oxidation to
the disulfide form.
PeroynitriteStimulates theSpecfic
Mitohondrial Ca2+ ReleasePathway
Because ONOO- oxidizes thiols and
because vicinal thiols control the specific
mitochondrial Ca2+ release pathway, we
tested whether ONOO- is able to activate
it (58). ONOO- induces Ca2+ release from
rat liver mitochondria. This release occurs
a) with preservation ofDY, b) when mito-
chondrial pyridine nucleotides are oxi-
dized but not when they are reduced,
c) parallel to NAD+ hydrolysis, d) in a
CSA-inhibitable manner, e) without inhi-
bition ofrespi-ration, andJ) without entry
of extramitochondrial solutes such as
sucrose into mitochondria. These findings
convincingly show that ONOO- can
mobilize mitochondrial Ca2+ by stimulat-
ing the specific, ADP-ribose-dependent
release pathway.
.NOInhibitsCytochrome
OxidaseandCusesCa2+
Release fromMitochondria
NO at submicromolar, physiologically
relevant concentrations potently de-
energizes isolated mitochondria (32).
Deenergization is observed when mito-
chondria use respiratory substrates such as
pyruvate plus malate, succinate, or ascor-
bate plus tetramethyl-phenylenediamine,
but not when mitochondria are energized
with ATP, and is due to a transient inhibi-
tion of cytochrome oxidase. The extent
and duration ofdeenergization are deter-
mined by the concentration of NO and
oxygen and the type of respiratory sub-
strate. The 'NO-induced changes of the
mitochondrial energy state are transient
and are paralleled by release and reuptake
of mitochondrial Ca2+. Importantly,
cytochrome oxidase is particularly sensitive
to NO at oxygen concentrations below
30 pM (59), i.e., at intracellular oxygen
tensions. These findings reveal a direct
action of NO on the mitochondrial respi-
ratory chain and suggest that NO exerts
some of its physiologic and pathologic
effects by deenergizing mitochondria.
In freshly prepared hepatocytes, NO
also deenergizes mitochondria (33).
Deenergization is reversible at low concen-
trations but longer lasting at higher NO
concentrations. The drop and the recovery
ofDY are accompanied by a rise and fall of
cytosolic Ca2+ levels. NO at higher concen-
trations, provided by nitrosoglutathione in
combination with dithiothreitol (GSNO/
DTT), kills hepatocytes. Killing is reduced
when the cytosolicCa2+ is chelated orwhen
Ca2+ cycling by mitochondria is prevented
by CSA. Apparently NO can kill cells by
releasing Ca2+ from mitochondria and
therebyflooding the cytosol with Ca2+.
bcl-2link OiddaiveStes Ca2
andtheMitochondrialMembrane
Potential toApoptosis
Given that bcl-2 elicits an antioxidative
response in cells, what are the biochemical
mechanism(s) by which bcl-2 prevents
apoptosis? It was shown (60,61) with the
aid of ruthenium red, an inhibitor ofthe
mitochondrial Ca2+ uptake, that one
mechanism is the prevention of ROS-
induced mitochondrial Ca2+ cycling, a
process that results in a collapse ofDY and
in cellular ATP depletion. Thus, bcl-2 pre-
vents disturbances of the cellular Ca2+
homeostasis and ROS production at the
mitochondrial level. On the basis of these
and other findings, it was suggested (6)
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that a prooxidant-induced Ca2+ release
from mitochondria, followed by Ca2+
cycling and ATP depletion, is a common
cause ofapoptosis. Accordingly, mainte-
nance of DY stabilizes mitochondria and
thereby prevents apoptosis. bcl-2 thus pro-
vides the link between the antioxidant
defense system, Ca2 , and DY [reviewed by
Bornkamm and Richter (62)]. In this con-
text it is interesting to recall that many car-
cinoma cells have an increased DY (63). As
prevention of apoptosis seems to con-
tribute to carcinogenesis, it is conceivable
that DY contributes to the decision
between the life and death ofacell.
NO andONO0 inApoptosis
Early studies had indicated that NO can
cause (64-67) or inhibit (68) apoptosis. It
had also been found that ONOO-
induces apoptosis in a time- and concen-
tration-dependent manner (26) and that
depending on the concentration of
ONOO-, cells die either by apoptosis or
necrosis (69). Recent studies have now
made it clear that, depending on the cell
type and trigger ofapoptosis, NO and its
congeners indeed either stimulate or
abrogate apoptotic cell death (70), and
S-nitrosylation regulates the balance
between apoptosis and necrosis (71). The
mechanisms by which the reactive nitro-
gen species act is not always evident, but
they comprise gene activation, DNA dam-
age, poly(ADP-ribose) polymerase and
protease modulation. Apoptosis is inhib-
ited by NO and its congeners in neuro-
blastoma cells (72), human embryonic
kidney HEK-293 cells (73), hepatocytes
(74-76), endothelial cells (77-79), and
human leukocytes (80). Apoptosis is stim-
ulated by NO and its congeners in lung
epithelial cells (81), intestinal epithelial
cells (82), endothelial cells (83), fibro-
blasts (84), hematopoietic cells (85),
vasular smooth muscle cells (86), HL-60
cells (87-89), mesangial cells (90,91), T
lymphocytes (92,93), macrophages
(94-96), melanoma cells (97), colon
cancer cells (98), hypothalamic cells (99),
and neurons (100-103) but not in glial
cells (103).
Whether the NO congeners cause
apoptosis because of interference with
mitochondrial respiration or Ca2+ han-
dling is unclear, but it should be noted
that the GSNO/DTT-induced killing
of hepatocytes (33) appears to engage
mitochondrial Ca2+ cycling. Other
investigators have proposed that NO
induces apoptosis via triggering the mito-
chondrial permeability transition (104).
Conclusion
An exciting new aspect in biology is the
discovery that NO congeners have an enor-
mous impact on mitochondria. NOS is
active inside mitochondria. Physiologic
concentrations of NO at physiologic cellu-
lar oxygen pressure inhibit cytochrome oxi-
dase and thereby respiration. A transient
inhibition ofcytochrome oxidase by NO
appears to be used in some forms of cell
signaling. ONOO-, the product of the
reaction between superoxide anion radicals
and NO, can stimulate the specific cal-
cium release pathway from mitochondria
by oxidizing some vicinal thiols in mito-
chondria. Mounting evidence indicates
that mitochondrial calcium handling and
its modulation by reactive nitrogen species
is important for apoptotic cell death. It
appears that NO and its congeners can
induce apoptosis by destabilizing mito-
chondria via deenergization and/or by
inducing a specific Ca2+ release followed by
Ca2+ cycling.
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